These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 34552932)

  • 1. Glucose Metabolism and Glucose Transporters in Breast Cancer.
    Shin E; Koo JS
    Front Cell Dev Biol; 2021; 9():728759. PubMed ID: 34552932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors.
    Naik A; Decock J
    Front Oncol; 2020; 10():598626. PubMed ID: 33324565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype.
    Choi J; Kim DH; Jung WH; Koo JS
    Breast Cancer Res; 2013; 15(5):R78. PubMed ID: 24020991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic phenotypes in triple-negative breast cancer.
    Kim S; Kim DH; Jung WH; Koo JS
    Tumour Biol; 2013 Jun; 34(3):1699-712. PubMed ID: 23443971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic phenotype of bladder cancer.
    Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
    Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
    Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancer.
    Brauer HA; Makowski L; Hoadley KA; Casbas-Hernandez P; Lang LJ; Romàn-Pèrez E; D'Arcy M; Freemerman AJ; Perou CM; Troester MA
    Clin Cancer Res; 2013 Feb; 19(3):571-85. PubMed ID: 23236214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Glucose Transporters for Breast Cancer Therapy: The Effect of Natural and Synthetic Compounds.
    Barbosa AM; Martel F
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31936350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamine metabolism in breast cancer and possible therapeutic targets.
    Li S; Zeng H; Fan J; Wang F; Xu C; Li Y; Tu J; Nephew KP; Long X
    Biochem Pharmacol; 2023 Apr; 210():115464. PubMed ID: 36849062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer.
    Varghese E; Samuel SM; Líšková A; Samec M; Kubatka P; Büsselberg D
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32806533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathways related to glutamine metabolism, glutamine inhibitors and their implication for improving the efficiency of chemotherapy in triple-negative breast cancer.
    Delgir S; Bastami M; Ilkhani K; Safi A; Seif F; Alivand MR
    Mutat Res Rev Mutat Res; 2021; 787():108366. PubMed ID: 34083056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Pentose Phosphate Pathway in Cancer: Regulation and Therapeutic Opportunities.
    Ghanem N; El-Baba C; Araji K; El-Khoury R; Usta J; Darwiche N
    Chemotherapy; 2021; 66(5-6):179-191. PubMed ID: 34775382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial metabolism in cancer metastasis: visualizing tumor cell mitochondria and the "reverse Warburg effect" in positive lymph node tissue.
    Sotgia F; Whitaker-Menezes D; Martinez-Outschoorn UE; Flomenberg N; Birbe RC; Witkiewicz AK; Howell A; Philp NJ; Pestell RG; Lisanti MP
    Cell Cycle; 2012 Apr; 11(7):1445-54. PubMed ID: 22395432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferating tumor cells mimick glucose metabolism of mature human erythrocytes.
    Ghashghaeinia M; Köberle M; Mrowietz U; Bernhardt I
    Cell Cycle; 2019 Jun; 18(12):1316-1334. PubMed ID: 31154896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino Acid Transporters and Glutamine Metabolism in Breast Cancer.
    Cha YJ; Kim ES; Koo JS
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized ATM-mediated glycolysis enhancement in breast cancer-associated fibroblasts contributes to tumor invasion through lactate as metabolic coupling.
    Sun K; Tang S; Hou Y; Xi L; Chen Y; Yin J; Peng M; Zhao M; Cui X; Liu M
    EBioMedicine; 2019 Mar; 41():370-383. PubMed ID: 30799198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using the "reverse Warburg effect" to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers.
    Witkiewicz AK; Whitaker-Menezes D; Dasgupta A; Philp NJ; Lin Z; Gandara R; Sneddon S; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Mar; 11(6):1108-17. PubMed ID: 22313602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between the Warburg effect and progression of triple-negative breast cancer.
    Liu S; Li Y; Yuan M; Song Q; Liu M
    Front Oncol; 2022; 12():1060495. PubMed ID: 36776368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Transcription Coregulator RIP140 Inhibits Cancer Cell Proliferation by Targeting the Pentose Phosphate Pathway.
    Jacquier V; Gitenay D; Cavaillès V; Teyssier C
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer.
    Munkácsy G; Santarpia L; Győrffy B
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.